Effects of carcinogen-induced transcription factors on the activation of hepatitis B virus expression in human hepatoblastoma HepG2 cells and its implication on hepatocellular carcinomas
Corresponding Author
Ranjit Banerjee Ph.D.
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY
Department of Microbiology and Immunology, New York Medical College, Basic Science Building Room 340, Valhalla, NY, 10595. fax: 914-594-4899.===Search for more papers by this authorLorraine Caruccio
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY
Search for more papers by this authorYu Jing Zhang
School of Public Health, Columbia University, New York, NY
Search for more papers by this authorRegina M. Santella
School of Public Health, Columbia University, New York, NY
Search for more papers by this authorCorresponding Author
Ranjit Banerjee Ph.D.
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY
Department of Microbiology and Immunology, New York Medical College, Basic Science Building Room 340, Valhalla, NY, 10595. fax: 914-594-4899.===Search for more papers by this authorLorraine Caruccio
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY
Search for more papers by this authorYu Jing Zhang
School of Public Health, Columbia University, New York, NY
Search for more papers by this authorRegina M. Santella
School of Public Health, Columbia University, New York, NY
Search for more papers by this authorAbstract
To elucidate the molecular mechanisms involved in the action of common carcinogens, which can act as important cofactors in modulating hepatitis B virus–mediated hepatocellular carcinogenesis, we have investigated the influence of aflatoxin B1 (AFB), a potent liver carcinogen, as well as benzo[a]pyrene (BP) and 4-aminobiphenyl (4-ABP), carcinogens in cigarette smoke, on the induction of various transcription factors in human hepatoblastoma HepG2 cells. DNA electrophoretic mobility shift assays were performed with nuclear extracts from HepG2 cells treated with 10 μmol/L AFB, 40 μmol/L BP, or 300 μmol/L 4-ABP for 6 and 24 hours. Eight- and 6-fold increases in nuclear transcription factor κB (NF-κB), and 5- and 10-fold increases in activated protein (AP-1) transcription factor were observed with 24 hours AFB and BP treatments, respectively, whereas 4-ABP treatment resulted in an approximately 4-fold induction of both NF-κB and AP-1. Moreover, 4-ABP gave the strongest NF-κB activation in 6 hours of treatment. Four- and 10-fold activation of stress protein was detected by a consensus heat shock factor (HSF) sequence binding probe, with AFB and BP treatments, respectively. DNA adducts were observed by immunoassays in HepG2 cells treated with AFB and BP but not with 4-ABP. Increased human hepatitis B virus (HBV) surface antigen (HBsAg) synthesis was detected in AFB- and BP-treated HepG2 cells following transfection with recircularized HBV DNA. These data suggest that certain carcinogen-induced transcription factors may influence viral carcinogenesis and initiate hepatocellular carcinomas (HCC).
REFERENCES
- 1 Tiollais P, Charnay P, Vyas GN. Biology of hepatitis B virus. Science 1981; 213: 406–411.MEDLINE
- 2 Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495.MEDLINE
- 3 Ganem D, Varmus HE. The molecular biology of the hepatitis B virus. Annu Rev Biochem 1987; 56: 651–693.MEDLINE
- 4 Sherker AH, Marion PL. Hepadnaviruses and hepatocellular carcinoma. Annu Rev Microbiol 1991; 45: 475–508.MEDLINE
- 5 Robinson WS. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu Rev Med 1994; 45: 297–323.MEDLINE
- 6 Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29–60.MEDLINE
- 7 Ghosh S, Van Duyne G, Ghosh S, Sigler PB. Structure of NF-κB p50 homodimer bound to a κB site. Nature (London) 1995; 373: 303–310.MEDLINE
- 8 Baeuerle P, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540–546.MEDLINE
- 9 Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–681.MEDLINE
- 10 Miyamoto S, Verma IM. Rel.NF-κB/IκB story. Adv Cancer Res 1995; 66: 255–291.MEDLINE
- 11 Banerjee R, Karpen S, Siekevitz M, Lengyel G, Bauer J, Acs G. Tumor necrosis factor-alpha induces a kappa B sequence-specific DNA-binding protein in human hepatoblastoma HepG2 cells. Hepatology 1989; 10: 1008–1013.MEDLINE
- 12 Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987; 49: 729–739.MEDLINE
- 13 Hasmall SC, Pyrah ITG, Soames AR, Roberts RA. Expression of the immediate-early genes, c-fos, c-jun, and c-myc: a comparison in rats of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Fund Appl Toxicol 1997; 40: 129–137.
- 14 Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993; 9: 601–634.MEDLINE
- 15 Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993; 259: 1409–1410.MEDLINE
- 16 Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 1995; 11: 441–469.MEDLINE
- 17 Morimoto RI, Jurvich DA, Kroeger PE, Mathur SK, Murphy SP, Nakai A, Sarge K, et al. Regulation of heat shock gene transcription by a family of heat shock factors. In: RI Morimoto, A Tissieres, C Georgopoulos eds. The Biology of Heat Shock Proteins and Molecular Chaperones. Vol 26. Cold Spring Harbor Press Monograph Series. Cold Spring Harbor: Cold Spring Harbor Press, 1994: 417–455.
- 18 Furlini G, Vignoli M, Re M, Gibellini C, Ramazzotti E, Zauli G, La Placa M. Human immunodeficiency virus type 1 interaction with the membrane of CD4+ cells induces the synthesis and nuclear translocation of 70K heat shock protein. J Gen Virol 1994; 75: 193–199.MEDLINE
- 19 Bohen SP, Yamamoto KR. Modulation of steroid receptor signal transduction by heat shock proteins. In: RI Morimoto, A Tissieres, C Georgopoulos eds. The Biology of Heat Shock Proteins and Molecular Chaperones. Vol 26. Cold Spring Harbor Press Monograph Series. Cold Spring Harbor: Cold Spring Harbor Press, 1994: 313–334.
- 20 Hu J, Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci U S A 1996; 93: 1060–1064.MEDLINE
- 21 Hu J, Toft DO, Seeger C. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J 1997; 16: 59–68.MEDLINE
- 22 Hertzog PJ, Lindsay-Smith JR, Garner RC. A high pressure liquid chromatography study on the removal of DNA-bound aflatoxin B1 in rat liver and in vitro. Carcinogenesis 1980; 1: 787–793.
- 23 Menzie CA, Potoki BB, Santodonato J. Exposure to carcinogenic PAHs in the environment. Environ Sci Technol 1992; 26: 1278–1284.
- 24 Phillips DH. Fifty years of benzo[a]pyrene. Nature 1983; 303: 468–472.MEDLINE
- 25 Vineis P. Epidemiological models of carcinogenesis: the example of bladder cancer. Cancer Epidemiol Biomarkers Prev 1992; 1: 149–153.MEDLINE
- 26 Poirier MC, Fullerton NF, Smith BA, Beland FA. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis 1995; 16: 2917–2921.MEDLINE
- 27 Pizzella T, Banerjee R. Identification of a human immunodeficiency virus type-1 TAR binding protein in human hepatoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression. DNA Cell Biol 1994; 13: 67–74.MEDLINE
- 28 Caruccio L, Banerjee R. An efficient method for simultaneous isolation of biologically active transcription factors and DNA. J Immunol Meth 1999; 230: 1–10.
- 29 Karpen S, Banerjee R, Zelent A, Price P, Acs G. Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol 1988; 8: 5159–5165.MEDLINE
- 30 Starcich B, Ratner L, Josephs SF, Okamoto T, Gallo RC, Staal FW. Characterization of long terminal repeat sequences of HTLV-III. Science 1985; 227: 538–540.MEDLINE
- 31 Northrop JP, Ullman KS, Crabtree GR. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 1993; 268: 2917–2923.MEDLINE
- 32 Goldenberg CJ, Luo Y, Fenna M, Baler R, Weinmann R, Voellmy R. Purified human factor activates heat shock promoter in a HeLa cell-free transcription system. J Biol Chem 1988; 263: 19734–19739.MEDLINE
- 33 Zhang YJ, Chen JC, Haghighi B, Yang GY, Hsieh LL, Wang LW, Santella RM. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissues by indirect immunofluorescence analysis. Cancer Res 1991; 51: 1720–1725.MEDLINE
- 34 Al-Atrash J, Zhang YJ, Lin D, Kadlubar FF, Santella RM. Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. Chem Res Toxicol 1995; 8: 747–752.MEDLINE
- 35 Santella RM, Weston A, Perera FP, Trivers GT, Harris CC, Young TL, Nguyen D, et al. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis 1988; 9: 1265–1269.MEDLINE
- 36 Poirier MC, Santella RM, Weinstein IB, Grunberger D, Yuspa SH. Quantitation of benzo[a]pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res 1980; 40: 412–416.MEDLINE
- 37 Banerjee R, Price P, Sung MW, Karpen S, Acs G. Selective inhibition of hepatitis B virus and human immunodeficiency virus sequence-promoted gene expression by cotransfected poly(I):poly(C). Virology 1990; 179: 410–415.MEDLINE
- 38 Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinker CA, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145–1156.MEDLINE
- 39 Pasquinelli C, Bhavani K, Chisari FV. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 1992; 52: 2823–2829.MEDLINE
- 40 Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19: 222–226.MEDLINE
- 41 Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A 1997; 94: 14707–14712.MEDLINE
- 42 Santella RM. The epidemiology of primary hepatocellular cancer. New Perspectives Cancer Diagnoses Manage 1995; 3: 3–14.
- 43
Wang L-Y,
Hatch M,
Chen C-J,
Levin B,
You S-L,
Wu M-H,
Wu W-P, et al.
Aflatoxin exposure and the risk of hepatocellular carcinoma in Taiwan.
Int J Cancer
1996;
67: 620–625.MEDLINE
10.1002/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W PubMed Web of Science® Google Scholar
- 44 Kaplanski C, Chisari FV, Wild CP. Minisatellite rearrangements are increased in liver tumours induced by transplacental aflatoxin B treatment of hepatitis B1 virus transgenic mice, but not in spontaneously arising tumours. Carcinogenesis 1997; 18: 633–639.MEDLINE
- 45 Wang L-Y, Chen CJ, Zhang Y-J, Tsai W-Y, Lee P-H, Feitelson MA, Lee C-S, et al. 4-aminobiphenyl-DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Amer J Epi 1998; 147: 315–323.
- 46 Denissenko MF, Pao A, Tang MS, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996; 274: 430–432.MEDLINE
- 47 Wu X, Zhao Y, Honn SE, Tomlinson GE, Minna JD, Hong WK, Spitz MR. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res 1998; 58: 1605–1608.MEDLINE
- 48 Hess MT, Gunz D, Luneva N, Geacintov NE, Naegeli H. Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Mol Cell Biol 1997; 17: 7069–7076.MEDLINE
- 49 Parrish AR, Fisher R, Bral CM, Burghardt RC, Gandolfi AJ, Brendel K, Ramos KS. Benzo(a)pyrene-induced alterations in growth-related gene expression and signaling in precision-cut adult rat liver and kidney slices. Toxicol Applied Pharmacol 1998; 152: 302–308.
- 50 Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993; 12: 3879–3891.MEDLINE